Revvity Announces Q3 Earnings Call
The company releases financial results and hosts a conference call on November 3, 2026.
Latest Revvity News & Updates
See the latest news and media coverage for Revvity. We track all announcements, press releases, and industry mentions in real time, all in one place.
Health science technologies and services company
revvity.com- Headquarters
- Waltham, United States
- Founded year
- 2023
- Company type
- Public company
- Number of employees
- 10,000+
Last updated
Latest news about Revvity
In short: Revvity raised its 2026 guidance after beating Q2 estimates and agreed to divest its China Immunodiagnostics business.
Company announcements
Revvity reports second quarter 2026 financial results
Revenue reached $730 million, adjusted EPS hit $1.41, and guidance was raised; it also agreed to divest China Immunodiagnostics.
Revvity announces Goodwill Ambassador for newborn screening in Kenya
The announcement followed a visit to Revvity's Turku site and strategic dialogues with Kenyan and Finnish officials.
Revvity launches Signals AI for accelerating scientific R&D
The framework uses natural language and LLMs within the Signals One platform to help scientists search, understand, and act on complex data while ensuring traceability and scientific rigor.
Media coverage
Revvity Shares Rise on Launch of Child Type 1 Diabetes Screening Test
Revvity (RVTY) shares rose 3.7% in Thursday trading after the company launched its GSP T1D 3plex kit, a fully automated test that helps identify children...
Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test
In company news, Oracle (ORCL) issued a force majeure notice to Project Jupiter's developer, a unit of Blue Owl Capital (OWL), seeking to defer payments...
Goldman Sachs Adjusts Price Target on Revvity to $140 From $100, Keeps Neutral Rating
Learn more Revvity (RVTY) has an average rating of hold and mean price target of $128.13, according to analysts polled by FactSet.
Revvity stock slips as CFRA downgrades (RVTY:NYSE)
Revvity (RVTY) stock dips as CFRA downgrades the company to Hold from Buy, citing valuation concerns. Read more here.
Never miss news about Revvity
Track Revvity and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Revvity competitors & trending companies
Browse news for competitors to Revvity and other trending companies.
Agilent
DiaSorin
Danaher
PerkinElmer
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC
Kriminalvården
Archus
Nyréns
Peab
MVB
VGR fastigheter
AIX
ByggDialog
Tengbom
LINK
Dynacon
Delphidata
Waystream
Netnod
Open Infra
PENN Entertainment
BrandCrowd